139 related articles for article (PubMed ID: 10623743)
1. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.
Das K; Bohl J; Vande Pol SB
J Virol; 2000 Jan; 74(2):812-6. PubMed ID: 10623743
[TBL] [Abstract][Full Text] [Related]
2. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein.
Bohl J; Das K; Dasgupta B; Vande Pol SB
Virology; 2000 May; 271(1):163-70. PubMed ID: 10814581
[TBL] [Abstract][Full Text] [Related]
3. Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.
Vande Pol SB; Brown MC; Turner CE
Oncogene; 1998 Jan; 16(1):43-52. PubMed ID: 9467941
[TBL] [Abstract][Full Text] [Related]
4. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53.
Cooper B; Schneider S; Bohl J; Jiang Yh; Beaudet A; Vande Pol S
Virology; 2003 Feb; 306(1):87-99. PubMed ID: 12620801
[TBL] [Abstract][Full Text] [Related]
5. Transformation by bovine papillomavirus type 1 E6 requires paxillin.
Wade R; Brimer N; Vande Pol S
J Virol; 2008 Jun; 82(12):5962-6. PubMed ID: 18385245
[TBL] [Abstract][Full Text] [Related]
6. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.
Chen JJ; Reid CE; Band V; Androphy EJ
Science; 1995 Jul; 269(5223):529-31. PubMed ID: 7624774
[TBL] [Abstract][Full Text] [Related]
7. Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.
Ned R; Allen S; Vande Pol S
J Virol; 1997 Jun; 71(6):4866-70. PubMed ID: 9151888
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
Chen JJ; Hong Y; Androphy EJ
Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
[TBL] [Abstract][Full Text] [Related]
9. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
[TBL] [Abstract][Full Text] [Related]
10. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP.
Be X; Hong Y; Wei J; Androphy EJ; Chen JJ; Baleja JD
Biochemistry; 2001 Feb; 40(5):1293-9. PubMed ID: 11170455
[TBL] [Abstract][Full Text] [Related]
11. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.
Tong X; Howley PM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4412-7. PubMed ID: 9114003
[TBL] [Abstract][Full Text] [Related]
12. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase.
Tong X; Salgia R; Li JL; Griffin JD; Howley PM
J Biol Chem; 1997 Dec; 272(52):33373-6. PubMed ID: 9407131
[TBL] [Abstract][Full Text] [Related]
13. Interactions between E6, FAK, and GIT1 at paxillin LD4 are necessary for transformation by bovine papillomavirus 1 E6.
Brimer N; Wade R; Vande Pol S
J Virol; 2014 Sep; 88(17):9927-33. PubMed ID: 24942580
[TBL] [Abstract][Full Text] [Related]
14. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
Drews CM; Brimer N; Vande Pol SB
PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
[TBL] [Abstract][Full Text] [Related]
16. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of the interactions of the E6 proteins from cutaneous and genital papillomaviruses with p53 and E6AP in correlation to their transforming potential.
Elbel M; Carl S; Spaderna S; Iftner T
Virology; 1997 Dec; 239(1):132-49. PubMed ID: 9426453
[TBL] [Abstract][Full Text] [Related]
18. Association of papillomavirus E6 proteins with either MAML1 or E6AP clusters E6 proteins by structure, function, and evolutionary relatedness.
Brimer N; Drews CM; Vande Pol SB
PLoS Pathog; 2017 Dec; 13(12):e1006781. PubMed ID: 29281732
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.
Zanier K; Charbonnier S; Sidi AO; McEwen AG; Ferrario MG; Poussin-Courmontagne P; Cura V; Brimer N; Babah KO; Ansari T; Muller I; Stote RH; Cavarelli J; Vande Pol S; Travé G
Science; 2013 Feb; 339(6120):694-8. PubMed ID: 23393263
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
